For years , doctors have sought effective therapies for severe mood disorders. Recently suggests this novel drug therapy, provided typically intravenously , appears to offer a significant opportunity for individuals who haven’t responded from standard antidepressants . Though largely considered an experimental intervention, early studies are reve